Home
About
Overview
Sharing Data
ORCID
Help
History (46)
NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment.
Merosin-deficient congenital muscular dystrophy with mental retardation and cerebellar cysts unlinked to the LAMA2, FCMD and MEB loci.
Who keeps the gate?
Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers.
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
See All 46 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction. Expert Rev Cardiovasc Ther. 2006 Jul; 4(4):461-76.
View in:
PubMed
subject areas
Anticholesteremic Agents
Azetidines
Cardiovascular Diseases
C-Reactive Protein
Drug Therapy, Combination
Ezetimibe
Heptanoic Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Intestinal Absorption
Lipoproteins, LDL
Phytosterols
Pravastatin
Pyrroles
Simvastatin
authors with profiles
Michael Davidson